Literature DB >> 11133870

The balance between proteinases and inhibitors in a murine model of proliferative retinopathy.

S Majka1, P McGuire, S Colombo, A Das.   

Abstract

PURPOSE: To examine the expression of matrix metalloproteinases (MMPs) and their inhibitors during the development of retinal neovascularization (NV) in a mouse model.
METHODS: A well-characterized murine model of retinal NV was used to study the expression of specific MMPs (MMP-2, MMP-9, and MT1-MMP) and tissue inhibitor of metalloproteinases (TIMPs types 1, 2, and 3). NV of the retina was induced in mice by exposure to 75% O(2) from postnatal day (P)7 to P12, followed by return to room air from P12 to P17. Expression of MMP mRNA was analyzed by reverse transcription-polymerase chain reaction (RT-PCR). In addition, retinal tissue removed from control (without NV) and experimental animals (with NV) was analyzed for the expression of TIMP-1, TIMP-2, and TIMP-3 mRNA and protein using RT-PCR and Western blot analysis.
RESULTS: During the angiogenic period from P13 to P17, MMP-2 and -9, and MT1-MMP message expression increased in experimental retinas compared with control samples. The TIMP-2 message and protein levels increased steadily in the retina of control animals until P17. This was in contrast to that seen in the retinas of the experimental animals in which TIMP-2 message and protein remained low and significantly less than in control samples. There were no significant changes in TIMP-3 message levels in retinal tissues, and TIMP-1 message and protein were undetectable.
CONCLUSIONS: Correlation was made at the mRNA and protein levels of TIMP expression compared with that of MMPs in a murine model of retinal NV, which suggests a temporal role for MMP-2 and -9, MT1-MMP, and TIMP-2 in new vessel formation in response to hypoxic stimulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11133870

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment.

Authors:  Chrysanthos Symeonidis; Eudoxia Diza; Eleni Papakonstantinou; Efimia Souliou; George Karakiulakis; Stavros A Dimitrakos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-29       Impact factor: 3.117

2.  Efficacy of intravitreal captopril on oxygen-induced retinopathy in mice.

Authors:  Yu Di; Yi-Ou Zhang; Yang Yang; Ai-Yuan Wang; Yan Lu; Xiao-Long Chen
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

3.  Plasminogen activators promote excitotoxicity-induced retinal damage.

Authors:  Raghuveer S Mali; Mei Cheng; Shravan K Chintala
Journal:  FASEB J       Date:  2005-08       Impact factor: 5.191

4.  Inhibition of proliferative retinopathy by the anti-vascular agent combretastatin-A4.

Authors:  Jeremy Griggs; Jeremy N Skepper; Gerry A Smith; Kevin M Brindle; James C Metcalfe; Robin Hesketh
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

5.  Matrix metalloproteinase-9 contributes to choroidal neovascularization.

Authors:  Vincent Lambert; Carine Munaut; Maud Jost; Agnès Noël; Zena Werb; Jean-Michel Foidart; Jean-Marie Rakic
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

6.  Matrix metalloproteinase-9 and -2 enhance the ligand sensitivity of photoreceptor cyclic nucleotide-gated channels.

Authors:  Peter C Meighan; Starla E Meighan; Elizabeth D Rich; R Lane Brown; Michael D Varnum
Journal:  Channels (Austin)       Date:  2012-05-01       Impact factor: 2.581

7.  Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model.

Authors:  Jung-A Shin; Hwa Sun Kim; Andrew Vargas; Wan-Qing Yu; Yun Sung Eom; Cheryl Mae Craft; Eun-Jin Lee
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

8.  Macrophage metalloelastase (MMP-12) deficiency mitigates retinal inflammation and pathological angiogenesis in ischemic retinopathy.

Authors:  Jingming Li; Joshua J Wang; Qisheng Peng; Chen Chen; Mary Beth Humphrey; Jay Heinecke; Sarah X Zhang
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization.

Authors:  Jingjing Cai; Guibin Yin; Bing Lin; Xianwei Wang; Xiaoling Liu; Xiaoyan Chen; Dongsheng Yan; Ge Shan; Jia Qu; Shengzhou Wu
Journal:  J Neuroinflammation       Date:  2014-05-15       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.